Provided by Tiger Trade Technology Pte. Ltd.

VanEck Pharmaceutical ETF

110.63
-0.5150-0.46%
Volume:51.96K
Turnover:5.75M
Market Cap:1.01B
PE:89.64
High:111.04
Open:111.04
Low:110.01
Close:111.14
52wk High:118.00
52wk Low:85.91
Shares:9.09M
Float Shares:9.09M
Volume Ratio:0.34
T/O Rate:0.57%
Dividend:2.18
Dividend Rate:1.97%
EPS(TTM):1.23
EPS(LYR):0.7765
ROE:--
ROA:--
PB:--
PE(LYR):142.47

Loading ...

Perspective Therapeutics, - Co Sponsors Study; Merck Provides Pembrolizumab at no Cost

THOMSON REUTERS
·
Sep 14

One State's Battle to Stop People from Taking Unapproved Weight-Loss Drugs

Dow Jones
·
Sep 14

Novo Nordisk to Rebrand as Novo

Dow Jones
·
Sep 14

Big Pharma is Pouring Billions into China's Biotechs

Dow Jones
·
Sep 14

Novo Nordisk Stock Slides as GLP-1 Fears Mount

TIPRANKS
·
Sep 12

Heart Disease, a Historic Strength for Big Pharma, Becomes a Weakness - Heard on the Street

Dow Jones
·
Sep 12

ETF Weekly | MSTZ, SMST Surge 17%; AMUU, AMDL Jump 16%; USO Advances 9%; Oil Theme Gains

ETF Weekly
·
Sep 12

Novartis: More Pain on the Way?

Dow Jones
·
Sep 12

Sector Update: Healthcare

MT Newswires Live
·
Sep 12

Novo Nordisk Shares Fall After Morgan Stanley Downgrade

MT Newswires Live
·
Sep 12

Sector Update: Healthcare Stocks Ease in Afternoon Trading

MT Newswires Live
·
Sep 12

AbbVie Announces Q4 2026 Dividend of R$ 0.37 Per Unit, Payable Nov. 23

Reuters
·
Sep 12

DBS Keeps Their Buy Rating on Merck & Company (MRK)

TIPRANKS
·
Sep 12

AbbVie’s ECLIPSE Migraine Trial Completes, Setting Up a New Catalyst for ABBV

TIPRANKS
·
Sep 12

Novartis AG Falls Friday, Underperforms Market

Dow Jones
·
Sep 12

Novo Nordisk A/S Series B Stock Falls Friday, Underperforms Market

Dow Jones
·
Sep 12

Eli Lilly Stock (LLY) in Focus as Company Completes $3.8 Billion AtaiBeckley Purchase

TIPRANKS
·
Sep 11

Eli Lilly Completes Acquisition of AtaiBeckley

Reuters
·
Sep 11

Lilly Completes Acquisition of Ataibeckley to Advance Therapies for Treatment-Resistant Depression and Other Mental Health Conditions

THOMSON REUTERS
·
Sep 11

Analysts’ Top Healthcare Picks: Adagene (ADAG), AbbVie (ABBV)

TIPRANKS
·
Sep 11